Skip to content
Clinical Trials – home

Universidade De Santiago De Compostela

Verifiedinfo

Spain Calle Choupana Da S/n, 15706 Santiago De Compostela, Spain

  • 205 trials recruiting
  • Dermatitis atopic · Psoriatic arthropathy · Non-small cell lung cancer
  • Adults and children

About Specializations

Universidade De Santiago De Compostela in Santiago De Compostela, Spain specialises in clinical trials of conditions such as Dermatitis atopic, Psoriatic arthropathy, Non-small cell lung cancer, Arteriosclerosis, and other specialisations. This site conducts important research.

Main research areas of the site

Neoplasms and Blood Cancer Research

At Universidade De Santiago De Compostela, clinical research is focused on neoplasms, with a strong emphasis on hematology and cancers affecting the blood and lymphatic system. The studies are centered on treatment-naïve mantle cell lymphoma, exploring new approaches to improve outcomes for people newly diagnosed with this rare cancer.

  • Evaluating new treatment combinations for mantle cell lymphoma
  • Assessing how effectively therapies can produce deep remission in hematologic malignancies
  • Supporting better disease control for patients with newly diagnosed lymphoma

The research at this educational institution in Santiago De Compostela is aimed at testing whether modern treatment strategies can improve remission rates and strengthen care for patients with lymphoma.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Calle Choupana Da S/n15706 Santiago De CompostelaSpain
Recruiting now
205 trials
Conditions studied
205
Partner status
Verified

More sites in Santiago De CompostelaSpain

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

596 clinical trials

Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Indacaterol Acetate
  • Sponsor:Novartis Pharma AG
Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Ferrer Internacional S.A.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Enfortumab Vedotin
  • Sponsor:Eli Lilly & Co.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:MOLNUPIRAVIR
  • Sponsor:Merck Sharp & Dohme LLC
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Exelixis Inc.
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Diamedica Therapeutics Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Prax-628
  • Sponsor:Praxis Precision Medicines Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.